Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Envelope Protein gp41 | 10 | 2020 | 314 | 3.170 |
Why?
|
| Membrane Fusion | 7 | 2023 | 273 | 2.370 |
Why?
|
| HIV Envelope Protein gp120 | 7 | 2018 | 952 | 1.950 |
Why?
|
| Virus Internalization | 8 | 2023 | 501 | 1.840 |
Why?
|
| HIV-1 | 16 | 2020 | 6939 | 1.660 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 6 | 2020 | 370 | 1.560 |
Why?
|
| Cryoelectron Microscopy | 6 | 2023 | 571 | 1.440 |
Why?
|
| HIV Envelope Protein gp160 | 3 | 2019 | 99 | 1.280 |
Why?
|
| Models, Molecular | 13 | 2021 | 5456 | 1.250 |
Why?
|
| Immune Evasion | 2 | 2021 | 360 | 1.250 |
Why?
|
| Antibodies, Neutralizing | 10 | 2023 | 1978 | 1.170 |
Why?
|
| Protein Multimerization | 7 | 2021 | 970 | 1.170 |
Why?
|
| HIV Antibodies | 8 | 2020 | 1322 | 1.130 |
Why?
|
| Lipid Bilayers | 3 | 2023 | 381 | 0.840 |
Why?
|
| Receptors, CCR5 | 2 | 2019 | 497 | 0.710 |
Why?
|
| Protein Conformation | 7 | 2023 | 4011 | 0.670 |
Why?
|
| Antibodies, Viral | 7 | 2023 | 3176 | 0.660 |
Why?
|
| Receptors, HIV | 1 | 2018 | 162 | 0.640 |
Why?
|
| Antiviral Agents | 3 | 2022 | 2987 | 0.570 |
Why?
|
| Molecular Conformation | 1 | 2017 | 563 | 0.540 |
Why?
|
| Antigens | 2 | 2017 | 1466 | 0.480 |
Why?
|
| Gene Products, env | 3 | 2006 | 263 | 0.470 |
Why?
|
| Protein Binding | 8 | 2023 | 9386 | 0.440 |
Why?
|
| Protein Structure, Quaternary | 5 | 2014 | 436 | 0.400 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 1477 | 0.400 |
Why?
|
| HEK293 Cells | 5 | 2021 | 4204 | 0.390 |
Why?
|
| Viral Envelope Proteins | 2 | 2005 | 635 | 0.390 |
Why?
|
| Protein Folding | 1 | 2014 | 843 | 0.390 |
Why?
|
| Neutralization Tests | 5 | 2023 | 758 | 0.380 |
Why?
|
| Protein Structure, Tertiary | 7 | 2017 | 3846 | 0.350 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2021 | 407 | 0.340 |
Why?
|
| Protein Structure, Secondary | 4 | 2020 | 1246 | 0.340 |
Why?
|
| Surface Plasmon Resonance | 3 | 2020 | 274 | 0.340 |
Why?
|
| Simian immunodeficiency virus | 2 | 2005 | 846 | 0.340 |
Why?
|
| Antibodies, Monoclonal | 8 | 2023 | 9274 | 0.330 |
Why?
|
| Antigen-Antibody Complex | 1 | 2010 | 517 | 0.330 |
Why?
|
| Epitopes | 4 | 2022 | 2571 | 0.330 |
Why?
|
| AIDS Vaccines | 1 | 2015 | 938 | 0.320 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2021 | 474 | 0.310 |
Why?
|
| Virion | 3 | 2018 | 433 | 0.300 |
Why?
|
| Protein Subunits | 2 | 2021 | 959 | 0.300 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2008 | 3772 | 0.300 |
Why?
|
| Anti-HIV Agents | 2 | 2020 | 4256 | 0.300 |
Why?
|
| Antigens, Viral | 2 | 2021 | 1035 | 0.300 |
Why?
|
| Neurospora crassa | 2 | 1997 | 27 | 0.290 |
Why?
|
| Amino Acid Substitution | 2 | 2021 | 1791 | 0.280 |
Why?
|
| Receptors, Virus | 3 | 2020 | 648 | 0.270 |
Why?
|
| Aspartate Carbamoyltransferase | 1 | 2004 | 22 | 0.250 |
Why?
|
| Viral Vaccines | 1 | 2009 | 636 | 0.240 |
Why?
|
| Membrane Glycoproteins | 2 | 2005 | 3768 | 0.230 |
Why?
|
| HIV Antigens | 2 | 2018 | 347 | 0.230 |
Why?
|
| Crystallography, X-Ray | 4 | 2010 | 2011 | 0.220 |
Why?
|
| Ligands | 4 | 2018 | 3282 | 0.220 |
Why?
|
| Binding Sites | 3 | 2020 | 6114 | 0.220 |
Why?
|
| Peptidyl-Dipeptidase A | 2 | 2021 | 365 | 0.210 |
Why?
|
| Cell Line | 4 | 2021 | 15997 | 0.190 |
Why?
|
| Antibody Affinity | 1 | 2021 | 254 | 0.190 |
Why?
|
| CHO Cells | 3 | 2014 | 1406 | 0.190 |
Why?
|
| Dequalinium | 1 | 2020 | 8 | 0.190 |
Why?
|
| Multiprotein Complexes | 1 | 2006 | 1119 | 0.180 |
Why?
|
| Fluorescence Polarization | 1 | 2020 | 132 | 0.180 |
Why?
|
| HIV Infections | 4 | 2019 | 16718 | 0.180 |
Why?
|
| Cricetinae | 3 | 2014 | 2472 | 0.180 |
Why?
|
| Mutation | 7 | 2022 | 29786 | 0.170 |
Why?
|
| Structure-Activity Relationship | 2 | 2020 | 3129 | 0.170 |
Why?
|
| Mutant Proteins | 1 | 2021 | 500 | 0.170 |
Why?
|
| Life Cycle Stages | 1 | 2019 | 160 | 0.160 |
Why?
|
| Chemokine CCL5 | 1 | 2018 | 209 | 0.160 |
Why?
|
| Molecular Biology | 1 | 2022 | 596 | 0.160 |
Why?
|
| Ultracentrifugation | 2 | 2012 | 182 | 0.150 |
Why?
|
| Cell Membrane | 2 | 2020 | 3748 | 0.150 |
Why?
|
| Protein Engineering | 1 | 2021 | 540 | 0.150 |
Why?
|
| Chromatography, Gel | 2 | 2012 | 668 | 0.150 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1997 | 248 | 0.140 |
Why?
|
| Humans | 23 | 2023 | 744343 | 0.140 |
Why?
|
| Glycosylation | 3 | 2005 | 1126 | 0.140 |
Why?
|
| Molecular Structure | 1 | 2020 | 1899 | 0.130 |
Why?
|
| Solubility | 1 | 2017 | 1085 | 0.130 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2020 | 3760 | 0.130 |
Why?
|
| Genes, Fungal | 1 | 1996 | 455 | 0.120 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2020 | 1375 | 0.120 |
Why?
|
| Receptors, CXCR4 | 1 | 2019 | 726 | 0.120 |
Why?
|
| Vaccines, Synthetic | 1 | 2017 | 634 | 0.120 |
Why?
|
| Small Molecule Libraries | 1 | 2020 | 720 | 0.120 |
Why?
|
| DNA, Complementary | 1 | 1997 | 2050 | 0.120 |
Why?
|
| Immunoglobulin Fab Fragments | 2 | 2018 | 482 | 0.120 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 1996 | 371 | 0.120 |
Why?
|
| Complementarity Determining Regions | 1 | 2013 | 149 | 0.110 |
Why?
|
| Cricetulus | 1 | 2014 | 816 | 0.110 |
Why?
|
| DNA Primers | 1 | 1997 | 2892 | 0.110 |
Why?
|
| Plasmids | 1 | 1997 | 2307 | 0.100 |
Why?
|
| Escherichia coli | 1 | 2004 | 4217 | 0.100 |
Why?
|
| Amino Acid Motifs | 1 | 2013 | 936 | 0.100 |
Why?
|
| Cells, Cultured | 2 | 2023 | 19229 | 0.100 |
Why?
|
| Recombinant Proteins | 1 | 2021 | 6622 | 0.100 |
Why?
|
| Animals | 10 | 2023 | 168757 | 0.090 |
Why?
|
| Cytoplasm | 1 | 2015 | 1539 | 0.090 |
Why?
|
| Guinea Pigs | 1 | 2012 | 1386 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2023 | 5021 | 0.090 |
Why?
|
| Membranes, Artificial | 1 | 2009 | 378 | 0.080 |
Why?
|
| Molecular Sequence Data | 4 | 2005 | 18111 | 0.080 |
Why?
|
| Binding Sites, Antibody | 1 | 2008 | 349 | 0.080 |
Why?
|
| Immunity, Humoral | 1 | 2010 | 598 | 0.070 |
Why?
|
| RNA, Fungal | 2 | 1997 | 164 | 0.070 |
Why?
|
| Amino Acid Sequence | 3 | 2005 | 13815 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3870 | 0.060 |
Why?
|
| Moths | 1 | 2004 | 87 | 0.060 |
Why?
|
| Crystallization | 1 | 2005 | 524 | 0.060 |
Why?
|
| Dimerization | 1 | 2004 | 893 | 0.050 |
Why?
|
| Models, Biological | 2 | 2010 | 9583 | 0.050 |
Why?
|
| Evolution, Molecular | 2 | 2021 | 1940 | 0.050 |
Why?
|
| Microscopy, Electron | 1 | 2004 | 2645 | 0.050 |
Why?
|
| Circular Dichroism | 1 | 2000 | 354 | 0.050 |
Why?
|
| Kinetics | 1 | 2008 | 6473 | 0.040 |
Why?
|
| Cell Fusion | 1 | 2020 | 297 | 0.040 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2022 | 548 | 0.040 |
Why?
|
| Polysaccharides | 1 | 2005 | 1053 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2000 | 1801 | 0.040 |
Why?
|
| Cross-Linking Reagents | 1 | 2000 | 694 | 0.040 |
Why?
|
| Templates, Genetic | 1 | 1997 | 211 | 0.040 |
Why?
|
| Base Composition | 1 | 1997 | 293 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2000 | 1723 | 0.040 |
Why?
|
| Cytochrome b Group | 1 | 1996 | 60 | 0.030 |
Why?
|
| Retroelements | 1 | 1997 | 164 | 0.030 |
Why?
|
| Electron Transport Complex IV | 1 | 1996 | 189 | 0.030 |
Why?
|
| Genetic Complementation Test | 1 | 1996 | 562 | 0.030 |
Why?
|
| Mice | 3 | 2023 | 81183 | 0.030 |
Why?
|
| Protein Stability | 1 | 2016 | 557 | 0.030 |
Why?
|
| Viral Proteins | 1 | 2021 | 1900 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1996 | 798 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 1997 | 913 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1997 | 794 | 0.030 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2016 | 507 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2000 | 2751 | 0.030 |
Why?
|
| Arginine | 1 | 2016 | 944 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1996 | 2839 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2005 | 6196 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2023 | 9734 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2000 | 3494 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 1996 | 4320 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2020 | 5974 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 1996 | 2969 | 0.020 |
Why?
|
| Base Sequence | 1 | 1997 | 12797 | 0.020 |
Why?
|
| Peptides | 1 | 1996 | 4409 | 0.010 |
Why?
|
| Mitochondria | 1 | 1996 | 3520 | 0.010 |
Why?
|
| Gene Expression | 1 | 1996 | 7799 | 0.010 |
Why?
|
| Phenotype | 1 | 1996 | 16365 | 0.010 |
Why?
|
Concepts
(147)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(23)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_